RxSight, Inc.
RXSTNasdaq
$5.55
↓ -0.4%Jul 17 close · end-of-day
Price
1Y↓ -23.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$229.2M
Enterprise Value
$11.4M
P/E
—
P/S
1.8
P/B
0.9
EV/EBITDA
—
PEG
—
FCF Yield
-9.4%
Dividend Yield
—
Revenue (TTM)
$127.5M
Net Income (TTM)
-$7.7M
Free Cash Flow (TTM)
-$21.6M
Gross Margin
77.0%
Operating Margin
-43.4%
Net Margin
-6.0%
ROE
-2.9%
ROIC
-88.5%
Debt / Equity
—
Net Cash
$217.9M
Return 1Y
-24.8%
Company profile
RxSight, Inc. engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. The company was formerly known as Calhoun Vision, Inc.
- CEO
- Ronald M. Kurtz
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 220
- Headquarters
- California
- Website
- rxsight.com
Management & directors
- Goldshleger IlyaChief Operating Officer
- Gaines ScottChief Customer Officer
- Wilterding MarkChief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
RXST Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$30.9M↓ -18.5%
Diluted EPS-$0.38↑ +90.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $14.7M | $22.6M | $49.0M | $89.1M | $139.9M | $134.5M |
| Gross profit | $1.7M | $4.5M | $21.3M | $53.8M | $98.9M | $103.0M |
| Operating income | -$35.4M | -$52.8M | -$63.3M | -$50.1M | -$36.9M | -$48.2M |
| Net income | $27.6M | -$48.7M | -$66.80 | -$48.60 | -$27.50 | -$38.90 |
| Diluted EPS | $0.15 | -$3.57 | -$2.41 | -$1.41 | -$0.71 | -$0.95 |
| Operating cash flow | -$35.2M | -$44.7M | -$58.9M | -$41.6M | -$16.9M | -$15.5M |
| Free cash flow | -$37.7M | -$46.6M | -$61.2M | -$46.4M | -$22.4M | -$19.3M |
| Gross margin | 11.6% | 20.0% | 43.5% | 60.4% | 70.7% | 76.6% |
| Operating margin | -241.3% | -233.6% | -129.2% | -56.2% | -26.3% | -35.8% |
| Net margin | 187.9% | -215.5% | -0.0% | -0.0% | -0.0% | -0.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.9M | $35.3M | $40.2M | $37.9M | $33.6M | $30.3M | $32.6M | $30.9M |
| Gross profit | $24.3M | $25.2M | $28.8M | $28.3M | $25.2M | $24.2M | $25.3M | $23.5M |
| Operating income | -$8.3M | -$9.2M | -$8.6M | -$10.7M | -$14.0M | -$12.2M | -$11.3M | -$17.8M |
| Net income | -$6.1M | -$6.3M | $21.5M | -$8.2M | -$11.8M | -$9.8M | $29.8M | -$15.9M |
| Diluted EPS | -$0.16 | -$0.16 | -$0.14 | -$0.20 | -$0.29 | -$0.24 | -$0.22 | -$0.38 |
| Operating cash flow | -$4.0M | $650,000.00 | -$4.3M | -$8.8M | -$4.4M | -$1.2M | -$1.1M | -$10.9M |
| Free cash flow | -$5.5M | -$453,000.00 | -$5.1M | -$9.4M | -$5.9M | -$1.8M | -$2.3M | -$11.7M |
| Gross margin | 69.5% | 71.4% | 71.6% | 74.8% | 74.9% | 79.9% | 77.5% | 76.1% |
| Operating margin | -23.9% | -26.1% | -21.5% | -28.2% | -41.6% | -40.1% | -34.8% | -57.7% |
| Net margin | -17.4% | -17.9% | 53.5% | -21.6% | -35.0% | -32.4% | 91.4% | -51.4% |
Company news
Jul 17, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-17 | Warner Robert Keith | Award | 37,037 | — | — | filing |
| 2026-06-17 | PALMISANO ROBERT J | Award | 37,037 | — | — | filing |
| 2026-06-17 | Maniar Shweta | Award | 37,037 | — | — | filing |
| 2026-06-17 | Fountain Tamara | Award | 37,037 | — | — | filing |
| 2026-06-17 | LINK WILLIAM J PHD | Award | 37,037 | — | — | filing |
| 2026-06-17 | Corley Jesse Anderson | Award | 37,037 | — | — | filing |
| 2026-06-17 | COHEN RAYMOND W | Award | 30,864 | — | — | filing |
| 2026-06-17 | Tammenoms Bakker Juliet | Award | 37,037 | — | — | filing |
| 2026-06-17 | Andrews Julie | Award | 37,037 | — | — | filing |
| 2026-04-17 | Goldshleger Ilya· Chief Operating Officer | Option exercise | 12,489 | $4.13 | $51,579.57 | filing |
| 2026-02-28 | Wilterding Mark· Chief Financial Officer | Tax withholding | 8,068 | $7.61 | $61,397.48 | filing |
| 2026-02-28 | Gaines Scott· Chief Customer Officer | Tax withholding | 2,580 | $7.61 | $19,633.80 | filing |
| 2026-02-28 | Gaines Scott· Chief Customer Officer | Option exercise | 6,261 | — | — | filing |
| 2026-02-28 | Wilterding Mark· Chief Financial Officer | Option exercise | 20,441 | — | — | filing |
| 2025-09-25 | Goldshleger Ilya· See remarks | Option exercise | 15,096 | $4.34 | $65,516.64 | filing |
| 2025-09-25 | Goldshleger Ilya· See remarks | Option exercise | 8,349 | $4.13 | $34,481.37 | filing |
| 2025-07-31 | COHEN RAYMOND W | Award | 35,668 | $0.00 | $0.00 | filing |
Latest 17 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.